Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 15/20 | 0.73 |
| ▸ | TBXA2R | P21731 | 6/20 | 0.73 |
| ▸ | PTGDR | Q13258 | 5/20 | 0.73 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.73 |
| ▸ | DRD1 | P21728 | 1/20 | 0.73 |
| ▸ | CCKAR | P32238 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | HTR7 | P34969 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9445961 | 1.00 | PTGDR2 (0.73) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 | |
| SCHEMBL9833660 | 0.91 | PTGDR2 (0.87) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 | |
| SCHEMBL9373404 | 0.90 | PTGDR2 (0.80) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 | |
| SCHEMBL9373398 | 0.90 | PTGDR2 (0.80) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 | |
| SCHEMBL9446071 | 0.86 | PTGDR2 (0.74) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 | |
| SCHEMBL9446069 | 0.86 | PTGDR2 (0.74) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 | |
| SCHEMBL9870636 | 0.85 | PTGDR2 (0.83) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 | |
| Ramatroban SCHEMBL29030 | 0.85 | PTGDR2 (1.00) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 | |
| SCHEMBL8980256 | 0.85 | PTGDR2 (0.83) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 | |
| Ramatroban SCHEMBL20769768 | 0.85 | PTGDR2 (1.00) | PTGDR2TBXA2RPTGDRABCB11CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5204374-A | Anticoagulants; thromboxane A2-antagonist; antiischemic agents; cardiovascular disorders; asthma; antiallergens | BAYER AKTIENGESELLSCHAFT (DE) | 1993-04-20 | — | — | US | claimed |